1. Home
  2. CGEN vs EHTH Comparison

CGEN vs EHTH Comparison

Compare CGEN & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • EHTH
  • Stock Information
  • Founded
  • CGEN 1993
  • EHTH 1997
  • Country
  • CGEN Israel
  • EHTH United States
  • Employees
  • CGEN N/A
  • EHTH N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • EHTH Specialty Insurers
  • Sector
  • CGEN Health Care
  • EHTH Finance
  • Exchange
  • CGEN Nasdaq
  • EHTH Nasdaq
  • Market Cap
  • CGEN 125.3M
  • EHTH 105.1M
  • IPO Year
  • CGEN 2000
  • EHTH 2006
  • Fundamental
  • Price
  • CGEN $1.58
  • EHTH $4.05
  • Analyst Decision
  • CGEN
  • EHTH Buy
  • Analyst Count
  • CGEN 0
  • EHTH 4
  • Target Price
  • CGEN N/A
  • EHTH $8.50
  • AVG Volume (30 Days)
  • CGEN 522.7K
  • EHTH 423.4K
  • Earning Date
  • CGEN 11-10-2025
  • EHTH 11-05-2025
  • Dividend Yield
  • CGEN N/A
  • EHTH N/A
  • EPS Growth
  • CGEN N/A
  • EHTH N/A
  • EPS
  • CGEN N/A
  • EHTH 0.04
  • Revenue
  • CGEN $22,144,000.00
  • EHTH $542,951,000.00
  • Revenue This Year
  • CGEN N/A
  • EHTH $4.88
  • Revenue Next Year
  • CGEN $208.08
  • EHTH $3.42
  • P/E Ratio
  • CGEN N/A
  • EHTH $91.17
  • Revenue Growth
  • CGEN N/A
  • EHTH 16.79
  • 52 Week Low
  • CGEN $1.13
  • EHTH $3.18
  • 52 Week High
  • CGEN $2.66
  • EHTH $11.36
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 44.43
  • EHTH 39.67
  • Support Level
  • CGEN $1.61
  • EHTH $3.67
  • Resistance Level
  • CGEN $1.80
  • EHTH $5.26
  • Average True Range (ATR)
  • CGEN 0.11
  • EHTH 0.44
  • MACD
  • CGEN -0.03
  • EHTH -0.17
  • Stochastic Oscillator
  • CGEN 19.35
  • EHTH 18.39

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

Share on Social Networks: